A detailed history of Nextech Invest Ag transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 6,296,740 shares of RVMD stock, worth $273 Million. This represents 46.53% of its overall portfolio holdings.

Number of Shares
6,296,740
Previous 6,296,740 -0.0%
Holding current value
$273 Million
Previous $244 Million 16.75%
% of portfolio
46.53%
Previous 46.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $26.7 Million - $49.7 Million
1,457,211 Added 30.11%
6,296,740 $181 Million
Q1 2023

May 12, 2023

BUY
$20.76 - $30.09 $13.5 Million - $19.6 Million
650,000 Added 15.51%
4,839,529 $105 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $4.37 Million - $6.5 Million
250,000 Added 6.35%
4,189,529 $82.6 Million
Q1 2022

May 16, 2022

BUY
$17.31 - $26.4 $16.8 Million - $25.6 Million
971,315 Added 32.72%
3,939,529 $100 Million
Q4 2021

Feb 14, 2022

BUY
$24.35 - $33.7 $72.3 Million - $100 Million
2,968,214 New
2,968,214 $74.7 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Nextech Invest Ag Portfolio

Follow Nextech Invest Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nextech Invest Ag, based on Form 13F filings with the SEC.

News

Stay updated on Nextech Invest Ag with notifications on news.